Line 3: |
Line 3: |
| - [[ICCR datasets: Haemopoietic]] | | - [[ICCR datasets: Haemopoietic]] |
| ==Myeloid proliferations and neoplasms[[chapter['chapterTitle'|Overview Page Link]]== | | ==Myeloid proliferations and neoplasms[[chapter['chapterTitle'|Overview Page Link]]== |
− | *Myeloid precursor lesions
| + | ===Myeloid precursor lesions=== |
| ''Clonal Haematopoiesis'' | | ''Clonal Haematopoiesis'' |
| - [[Introduction]] | | - [[Introduction]] |
| - [[Clonal haematopoiesis]] | | - [[Clonal haematopoiesis]] |
| - [[Clonal cytopenias of undetermined significance]] | | - [[Clonal cytopenias of undetermined significance]] |
− | *Myeloproliferative neoplasms
| + | ===Myeloproliferative neoplasms=== |
| ''Myeloproliferative neoplasms'' | | ''Myeloproliferative neoplasms'' |
| - [[Introduction]] | | - [[Introduction]] |
Line 19: |
Line 19: |
| - [[Juvenile myelomonocytic leukaemia]] | | - [[Juvenile myelomonocytic leukaemia]] |
| - [[Myeloproliferative neoplasm, NOS]] | | - [[Myeloproliferative neoplasm, NOS]] |
− | *Mastocytosis
| + | ===Mastocytosis=== |
| - [[Introduction]] | | - [[Introduction]] |
| - [[Cutaneous mastocytosis]] | | - [[Cutaneous mastocytosis]] |
| - [[Systemic mastocytosis]] | | - [[Systemic mastocytosis]] |
| - [[Mast cell sarcoma]] | | - [[Mast cell sarcoma]] |
− | *Myelodysplastic neoplasms
| + | ===Myelodysplastic neoplasms=== |
| - [[Introduction]] | | - [[Introduction]] |
| ''Myelodysplastic neoplasms, with defining genetic abnormalities'' | | ''Myelodysplastic neoplasms, with defining genetic abnormalities'' |
Line 37: |
Line 37: |
| - [[Childhood myelodysplastic neoplasm with low blasts]] | | - [[Childhood myelodysplastic neoplasm with low blasts]] |
| - [[Childhood myelodysplastic neoplasm with increased blasts]] | | - [[Childhood myelodysplastic neoplasm with increased blasts]] |
− | *Myelodysplastic/myeloproliferative neoplasms
| + | ===Myelodysplastic/myeloproliferative neoplasms=== |
| - [[Introduction]] | | - [[Introduction]] |
| - [[Chronic myelomonocytic leukaemia]] | | - [[Chronic myelomonocytic leukaemia]] |
Line 43: |
Line 43: |
| - [[Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis]] | | - [[Myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and thrombocytosis]] |
| - [[Myelodysplastic/myeloproliferative neoplasm, NOS]] | | - [[Myelodysplastic/myeloproliferative neoplasm, NOS]] |
− | *Acute myeloid leukaemia
| + | ===Acute myeloid leukaemia=== |
| - [[Introduction]] | | - [[Introduction]] |
| ''Acute myeloid leukaemia with defining genetic abnormalities'' | | ''Acute myeloid leukaemia with defining genetic abnormalities'' |
Line 70: |
Line 70: |
| ''Myeloid sarcoma'' | | ''Myeloid sarcoma'' |
| - [[Myeloid sarcoma]] | | - [[Myeloid sarcoma]] |
− | *Myeloid neoplasms, secondary
| + | ===Myeloid neoplasms, secondary=== |
| ''Myeloid neoplasms and proliferations associated with antecedent or predisposing conditions'' | | ''Myeloid neoplasms and proliferations associated with antecedent or predisposing conditions'' |
| - [[Introduction]] | | - [[Introduction]] |
Line 76: |
Line 76: |
| - [[Myeloid neoplasms associated with germline predisposition]] | | - [[Myeloid neoplasms associated with germline predisposition]] |
| - [[Myeloid proliferations associated with Down syndrome]] | | - [[Myeloid proliferations associated with Down syndrome]] |
− | *Myeloid/lymphoid neoplasms
| + | ===Myeloid/lymphoid neoplasms=== |
| ''Myeloid/lymphoid neoplasms with eosinophilia and defining gene rearrangement'' | | ''Myeloid/lymphoid neoplasms with eosinophilia and defining gene rearrangement'' |
| - [[Introduction]] | | - [[Introduction]] |
Line 86: |
Line 86: |
| - [[Myeloid/lymphoid neoplasm with ETV6::ABL1 fusion]] | | - [[Myeloid/lymphoid neoplasm with ETV6::ABL1 fusion]] |
| - [[Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes]] | | - [[Myeloid/lymphoid neoplasms with other tyrosine kinase fusion genes]] |
− | *Acute leukaemias of mixed or ambiguous lineage
| + | ===Acute leukaemias of mixed or ambiguous lineage=== |
| - [[Introduction]] | | - [[Introduction]] |
| ''Acute leukaemia of ambiguous lineage with defining genetic abnormalities'' | | ''Acute leukaemia of ambiguous lineage with defining genetic abnormalities'' |
Line 100: |
Line 100: |
| ==Histiocytic/Dendritic cell neoplasms[[chapter['chapterTitle'|Overview Page Link]]== | | ==Histiocytic/Dendritic cell neoplasms[[chapter['chapterTitle'|Overview Page Link]]== |
| - [[Introduction]] | | - [[Introduction]] |
− | *Plasmacytoid dendritic cell neoplasms
| + | ===Plasmacytoid dendritic cell neoplasms=== |
| ''Plasmacytoid dendritic cell neoplasms'' | | ''Plasmacytoid dendritic cell neoplasms'' |
| - [[Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm]] | | - [[Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm]] |
| - [[Blastic plasmacytoid dendritic cell neoplasm]] | | - [[Blastic plasmacytoid dendritic cell neoplasm]] |
− | *Langerhans cell and other dendritic cell neoplasms
| + | ===Langerhans cell and other dendritic cell neoplasms=== |
| ''Langerhans cells neoplasms'' | | ''Langerhans cells neoplasms'' |
| - [[Langerhans cell histiocytosis]] | | - [[Langerhans cell histiocytosis]] |
Line 111: |
Line 111: |
| - [[Indeterminate dendritic cell tumour]] | | - [[Indeterminate dendritic cell tumour]] |
| - [[Interdigitating dendritic cell sarcoma]] | | - [[Interdigitating dendritic cell sarcoma]] |
− | *Histiocyte/macrophage neoplasms
| + | ===Histiocyte/macrophage neoplasms=== |
| ''Histiocytic neoplasms'' | | ''Histiocytic neoplasms'' |
| - [[Juvenile xanthogranuloma]] | | - [[Juvenile xanthogranuloma]] |
Line 120: |
Line 120: |
| ==B-cell lymphoid proliferations and lymphomas[[chapter['chapterTitle'|Overview Page Link]]== | | ==B-cell lymphoid proliferations and lymphomas[[chapter['chapterTitle'|Overview Page Link]]== |
| - [[Introduction to B-cell lymphoproliferative disorders and neoplasms]] | | - [[Introduction to B-cell lymphoproliferative disorders and neoplasms]] |
− | *Tumour like lesions with B-cell predominance
| + | ===Tumour like lesions with B-cell predominance=== |
| - [[Introduction]] | | - [[Introduction]] |
| - [[Reactive B-cell rich lymphoid proliferations that can mimic lymphoma]] | | - [[Reactive B-cell rich lymphoid proliferations that can mimic lymphoma]] |
Line 127: |
Line 127: |
| - [[Idiopathic multicentric Castleman disease]] | | - [[Idiopathic multicentric Castleman disease]] |
| - [[KSHV/HHV8-associated multicentric Castleman disease]] | | - [[KSHV/HHV8-associated multicentric Castleman disease]] |
− | *Precursor B-cell neoplasms
| + | ===Precursor B-cell neoplasms=== |
| ''B-lymphoblastic leukaemias/lymphomas'' | | ''B-lymphoblastic leukaemias/lymphomas'' |
| - [[Introduction]] | | - [[Introduction]] |
Line 144: |
Line 144: |
| - [[B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations]] | | - [[B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations]] |
| - [[B-lymphoblastic leukaemia/lymphoma, NOS]] | | - [[B-lymphoblastic leukaemia/lymphoma, NOS]] |
− | *Mature B-cell neoplasms
| + | ===Mature B-cell neoplasms=== |
| ''Pre-neoplastic and neoplastic small lymphocytic proliferations '' | | ''Pre-neoplastic and neoplastic small lymphocytic proliferations '' |
| - [[Introduction]] | | - [[Introduction]] |
Line 213: |
Line 213: |
| - [[Lymphomas arising in immune deficiency / dysregulation ]] | | - [[Lymphomas arising in immune deficiency / dysregulation ]] |
| - [[Inborn error of immunity-associated lymphoid proliferations and lymphomas]] | | - [[Inborn error of immunity-associated lymphoid proliferations and lymphomas]] |
− | *Hodgkin lymphoma
| + | ===Hodgkin lymphoma=== |
| - [[Introduction]] | | - [[Introduction]] |
| - [[Classic Hodgkin lymphoma ]] | | - [[Classic Hodgkin lymphoma ]] |
| - [[Nodular lymphocyte predominant Hodgkin lymphoma]] | | - [[Nodular lymphocyte predominant Hodgkin lymphoma]] |
− | *Plasma cell neoplasms and other diseases with paraproteins
| + | ===Plasma cell neoplasms and other diseases with paraproteins=== |
| - [[Introduction]] | | - [[Introduction]] |
| ''Monoclonal gammopathies'' | | ''Monoclonal gammopathies'' |
Line 239: |
Line 239: |
| ==T-cell and NK-cell lymphoid proliferations and lymphomas [[chapter['chapterTitle'|Overview Page Link]]== | | ==T-cell and NK-cell lymphoid proliferations and lymphomas [[chapter['chapterTitle'|Overview Page Link]]== |
| - [[Introduction]] | | - [[Introduction]] |
− | *Tumour-like lesions with T-cell predominance
| + | ===Tumour-like lesions with T-cell predominance=== |
| - [[Kikuchi-Fujimoto disease]] | | - [[Kikuchi-Fujimoto disease]] |
| - [[Autoimmune lymphoproliferative syndrome]] | | - [[Autoimmune lymphoproliferative syndrome]] |
| - [[Indolent T-lymphoblastic proliferation]] | | - [[Indolent T-lymphoblastic proliferation]] |
− | *Precursor T-cell neoplasms
| + | ===Precursor T-cell neoplasms=== |
| ''T-lymphoblastic leukaemia / lymphoma'' | | ''T-lymphoblastic leukaemia / lymphoma'' |
| - [[T-lymphoblastic leukaemia / lymphoma, NOS]] | | - [[T-lymphoblastic leukaemia / lymphoma, NOS]] |
| - [[Early T-precursor lymphoblastic leukaemia / lymphoma ]] | | - [[Early T-precursor lymphoblastic leukaemia / lymphoma ]] |
− | *Mature T-cell and NK-cell neoplasms
| + | ===Mature T-cell and NK-cell neoplasms=== |
| ''Mature T-cell and NK-cell leukaemias'' | | ''Mature T-cell and NK-cell leukaemias'' |
| - [[Introduction]] | | - [[Introduction]] |
Line 299: |
Line 299: |
| ==Stroma-derived neoplasms of lymphoid tissues[[chapter['chapterTitle'|Overview Page Link]]== | | ==Stroma-derived neoplasms of lymphoid tissues[[chapter['chapterTitle'|Overview Page Link]]== |
| - [[Introduction]] | | - [[Introduction]] |
− | *Mesenchymal dendritic cell neoplasms
| + | ===Mesenchymal dendritic cell neoplasms=== |
| ''Follicular dendritic cell neoplasms'' | | ''Follicular dendritic cell neoplasms'' |
| - [[Follicular dendritic cell sarcoma]] | | - [[Follicular dendritic cell sarcoma]] |
| - [[EBV-positive inflammatory follicular dendritic cell sarcoma]] | | - [[EBV-positive inflammatory follicular dendritic cell sarcoma]] |
| - [[Fibroblastic reticular cell tumour]] | | - [[Fibroblastic reticular cell tumour]] |
− | *Myofibroblastic tumours
| + | ===Myofibroblastic tumours=== |
| ''Myofibroblastic tumour'' | | ''Myofibroblastic tumour'' |
| - [[Intranodal palisaded myofibroblastoma]] | | - [[Intranodal palisaded myofibroblastoma]] |
− | *Spleen-specific vascular-stromal tumours
| + | ===Spleen-specific vascular-stromal tumours=== |
| ''Splenic vascular-stromal tumours'' | | ''Splenic vascular-stromal tumours'' |
| - [[Littoral cell angioma]] | | - [[Littoral cell angioma]] |